Tag: Capital’s
Legend Capital’s Portfolio Company Feima Robotics Assists China’s 38rd Antarctic Expedition with a Series of Civilian UAV Products
On April 26, 2022, the expedition ship Xuelong 2 for China’s 38th Antarctic expedition berthed at the Shanghai base dock. So far, China’s 38th Antarctic expedition, which lasted 174 days and traveled more than 33,000 nautical miles, has ended successfully. For the 38th Antarctic expedition, the Polar Surveying and Mapping Engineering Center of Heilongjiang Surveying and Mapping Geographic Information Bureau, the School of Surveying and Mapping of Sun Yat-sen University, and the Third Institute of the Ministry of Natural Resources both chose drones from Feima Robotics, a civilian UAV manufacturer in China, to assist in polar aerial photogrammetry. According to ... Read more
Legend Capital’s Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application of its product LX101 injection for the treatment of patients with Rpe65 biallelic mutation-associated inherited retinal degenerations (IRD) was approved by the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China. Founded in 2020, Innostellar Biotherapeutics is a biopharmaceutical startup company focusing on gene therapy for innovative drug discovery, manufacture, and commercialization. Its core team consists of scientists and professionals from world-renowned institutions and biopharmaceutical companies. Since its establishment, Innostellar Biotherapeutics has been working closely with ... Read more